5 Key Takeaways

• 1

  A retrospective study involving nearly 1,000 patients supports decellularized basement membrane grafts for neurotrophic keratitis intervention.

• 2

  The study published in Clinical Ophthalmology evaluated Biovance Ocular DBM grafts in patients with chronic subclinical or Mackie Stage 1 NK.

• 3

  Corneal epithelial resolution occurred in all eyes with complete follow-up, and functional corneal sensitivity improved significantly.

• 4

  Among eyes with abnormal baseline osmolarity, 70–82% normalized after treatment, and MMP-9 positivity decreased across all severity groups.

• 5

  Brandon Ayres suggests that neurotrophic keratitis is likely underdiagnosed and emphasizes the need for corneal sensitivity testing.